RN

Ramniwas Narsingdas Singi

Active Director Director DIN 00170532
DIN 00170532 First appointment Apr 1998 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 1998
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramniwas Narsingdas Singi

Data last updated:

Ramniwas Narsingdas Singi is a Director at Ace Scientific Private Limited (since 1998). The company operates in Healthcare.

DIN 00170532
Primary Designation Director
Industry Healthcare
First Appointment 20 Apr 1998
Oldest Company Age 28 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ace Scientific Private Limited U33125MH1998PTC114538
Director20 Apr 19981998Active

Board colleagues of Ramniwas Narsingdas Singi

NameDINCompanyDesignation
Mildred Fernandes Thelma00133240Ace Scientific Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Ace Scientific Private Limited
Premium access

Shareholding and investment profile for Ramniwas Narsingdas Singi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramniwas Narsingdas Singi

Ramniwas Narsingdas Singi currently holds 1 directorship: Ace Scientific Private Limited (Director, since 20 Apr 1998).

Ramniwas Narsingdas Singi was first appointed on 20 Apr 1998 as Director at Ace Scientific Private Limited.

The current boards of Ramniwas Narsingdas Singi's companies include Mildred Fernandes Thelma (Ace Scientific Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available